Mast Therapeutics Inc

Available to platforms
R StocksTrader
Mast Therapeutics Inc. (Ticker: MSTX) was a biopharmaceutical company focused on developing therapies for serious or life-threatening diseases. Its lead product candidate, vepoloxamer, was investigated as a treatment for sickle cell disease and heart failure. In 2017, Mast Therapeutics merged with Savara Inc., a company specializing in therapies for rare respiratory diseases, marking a strategic shift toward advancing treatments for orphan lung conditions.

Mast Therapeutics Inc (MSTX) on the NYSE Exchange

Company overview

Mast Therapeutics Inc is a publicly listed company from USA with shares traded on NYSE under the ticker MSTX. This page provides a live view of market pricing and an interactive chart to follow short and long-term moves without manual refresh. The latest streaming quotes for MSTX are bid 3.9 USD and ask 3.91 USD.

Use the chart to review recent momentum, identify key price areas, and track how Mast Therapeutics Inc is performing relative to your portfolio in 2026. If you are researching the instrument for trading or investing, add MSTX to your watchlist in R StocksTrader and compare it with other US and European shares, indices, and metals.

Key facts

  • Exchange: NYSE
  • Company: Mast Therapeutics Inc
  • Ticker: MSTX
  • Country: USA
  • Bid3.9 USD
  • Ask3.91 USD
  • Quotes: real-time, auto-updated

Risk

Risk Warning: Past performance of MSTX does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy, and then place an order for Mast Therapeutics Inc (MSTX) in R StocksTrader. Create and verify your profile, fund the account, search for MSTX, and choose the instrument type available to you. Add MSTX to your Watchlist to track moves and manage open positions throughout 2026.

MSTX trades on NYSE and is issued by Mast Therapeutics Inc. This page provides a live chart and continuously updated price data for the 2026 year so that you can follow intraday swings and longer trends. Before starting trading and placing orders, review trading hours, typical spreads, and fees in the terminal to make sure conditions for MSTX match your plan.

Quotes update automatically in real time. Current levels for MSTX are bid 3.9 USD and ask 3.91 USD. The spread is the difference between ask and bid and affects your effective entry and exit. Track MSTX in R StocksTrader and adjust your approach as market conditions change in 2026.